Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes

被引:10
|
作者
Konopnicki, Camille M. [1 ]
Dickmann, Leslie J. [2 ]
Tracy, Jeffrey M. [3 ]
Tukey, Robert H. [1 ]
Wienkers, Larry C. [2 ]
Foti, Robert S. [2 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Amgen Inc, Pharmacokinet & Drug Metab, Seattle, WA 98119 USA
[3] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA
关键词
UDP-Glucuronosyltransferase; siRNA; Protein interactions; Hepatocytes; HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN DRUG GLUCURONIDATION; IN-VITRO; METABOLIZING-ENZYMES; LIVER-MICROSOMES; CYTOCHROME-P450; MODULATION; EXPRESSION; HOMODIMERIZATION; INACTIVATION;
D O I
10.1016/j.abb.2013.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous experiments performed in recombinant systems have suggested that protein-protein interactions occur between the UGTs and may play a significant role in modulating enzyme activity. However, evidence of UGT protein protein interactions either in vivo or in more physiologically relevant in vitro systems has yet to be demonstrated. In this study, we examined oligomerization and its ability to affect glucuronidation in plated human hepatocytes. siRNA down regulation experiments and activity studies were used to examine changes in metabolite formation of one UGT isoform due to down regulation of a second UGT isoform. Selective siRNA directed towards UGT1A9 or UGT2B7 resulted in significant and selective decreases in their respective mRNA levels. As expected, the metabolism of the UGT1A9 substrate propofol decreased with UGT1A9 down regulation. Interestingly, UGT1A9 activity, but not UGT1A9 mRNA expression, was also diminished when UGT2B7 expression was selectively inhibited, implying potential interactions between the two isoforms. Minor changes to UGT1A4, UGT2B4 and UGT2B7 activity were also observed when UGT1A9 expression was selectively down regulated. To our knowledge, this represents the first piece of evidence that UGT protein-protein interactions occur in human hepatocytes and suggests that expression levels of UGT2B7 may directly impact the glucuronidation activity of selective UGT1A9 substrates. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 50 条
  • [31] Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9
    Ethell, BT
    Ekins, S
    Wang, JB
    Burchell, B
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) : 734 - 738
  • [32] Stereoselective Glucuronidation of Propafenone and Its Analogues by Human Recombinant UGT1A9
    Xie, Shenggu
    Zeng, Su
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (06) : 879 - 883
  • [33] Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
    Tsoutsikos, P
    Miners, JO
    Stapleton, A
    Thomas, A
    Sallustio, BC
    Knights, KM
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (01) : 191 - 199
  • [34] Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells
    Münzel, PA
    Schmohl, S
    Heel, H
    Kälberer, K
    Bock-Hennig, BS
    Bock, KW
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (05) : 569 - 573
  • [35] Influence of UGT1A9*3 and UGT2B7 (G-840A) polymorphisms on MPA metabolism in renal transplant recipients
    Djebli, N
    Picard, N
    Le Meur, Y
    Szelag, JC
    Rousseau, A
    Marquet, P
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 246 - 246
  • [36] Isolation and characterization of the human UGT2B7 gene
    Carrier, JS
    Turgeon, D
    Journault, K
    Hum, DW
    Bélanger, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) : 616 - 621
  • [37] Independent regulation of UGT 1A and 2B expression and PXR-correlated expression UGT2b7 in human livers
    Goyal, A
    Heydel, JM
    Lu, Y
    Czernik, P
    Little, J
    Lindblom, T
    Mackenzie, P
    Radominska-Pandya, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 187 - 187
  • [38] Genetic polymorphisms of UGT1A8, UGT1A9, UGT2B7 and ABCC2 in Chinese renal transplant recipients and a comparison with other ethnic populations
    Deng, Xiao-ying
    Wang, Chang-xi
    Wang, Xue-ding
    Bi, Hui-chang
    Chen, Xiao
    Li, Jia-li
    Huang, Min
    PHARMAZIE, 2013, 68 (04): : 240 - 244
  • [39] The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants
    Yang, Zi-zhao
    Li, Li
    Wang, Lu
    Yuan, Ling-min
    Xu, Ming-cheng
    Gu, Jing-kai
    Jiang, Hui-di
    Yu, Lu-shan
    Zeng, Su
    ACTA PHARMACOLOGICA SINICA, 2017, 38 (08) : 1184 - 1194
  • [40] The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants
    Zi-zhao Yang
    Li Li
    Lu Wang
    Ling-min Yuan
    Ming-cheng Xu
    Jing-kai Gu
    Hui-di Jiang
    Lu-shan Yu
    Su Zeng
    Acta Pharmacologica Sinica, 2017, 38 : 1184 - 1194